The USPTO granted CTL Amedica U.S. Patent No. 10,765,529 for articulating intervertebral devices, related tools, systems and methods.
The system addresses many complex challenges that are associated with traditional transforaminal lumbar interbody fusion (TLIF). For instance, the placement of a curved TLIF cage is often more challenging, given the overall implant footprint. CTL Amedica’s technology provides a streamlined articulating implant insertion tool. It allows for minimum tissue disruption, controlled re-positioning and efficient deployment of compatible, curved TLIF cages.
The TLIF instruments include articulating options that support a greater range of interbody movement during the insertion period, as well as a preferred entry angle into the prepared disc space.
“When a minimally invasive TLIF is performed, direct visualization of the disc space isn’t available during implantation. Lack of visualization may make proper implant placement extremely difficult and labor-intensive,” said Daniel Chon, CTL Amedica President and CEO. The company partnered with Dr. Nitin Kukkar and Jon Wing to develop this system.